Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5219_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Foreword
- •Preface
- •Contents
- •Editors and Contributors
- •About the Editors
- •Contributors
- •1.1 Introduction
- •1.2 Conventional Methods
- •1.2.1 Microscopy
- •1.2.2 Culture
- •1.2.3 Germ Tube Test
- •1.2.5 Carbohydrate Assimilation Test
- •1.2.6 Nitrogen Assimilation Test
- •1.2.7 Carbohydrate Fermentation Test
- •1.2.8 Urease Test
- •1.2.9 Tween 80 Opacity Test
- •1.3 Nonculture-Based Conventional Methods
- •1.3.1 Serological Methods
- •1.3.1.2 ß-d-Glucan
- •1.3.1.3 C. albicans Germ Tube Antibody Assay (CAGTA)
- •1.4 Nucleic Acid-Based Detection
- •1.4.1 Polymerase Chain Reaction (PCR)
- •1.4.3 Peptide Nucleic Acid FISH (PNA-FISH)
- •1.4.4 PCR-Based Innovative Diagnosis
- •1.4.5 FilmArray System
- •1.4.6 Sepsis Flow Chip
- •1.4.7 ePlex System
- •1.4.8 The T2 Candida Assay
- •1.5 Rapid Identification Systems
- •1.5.1 Manual Rapid Identification System
- •1.5.1.1 The API System
- •1.5.1.2 The VITEK System
- •1.5.2 Automatic Rapid Identification System
- •1.5.2.1 MALDI-TOF MS
- •1.5.2.2 The MALDI Sepsityper IVD Kit
- •1.5.2.3 The BioFire FilmArray BCID2 Panel
- •1.5.2.4 The Accelerate Pheno BC Panel
- •1.6 Advanced Diagnostics
- •1.6.2 Biosensor-Based Tests
- •1.6.3 Next-Generation Sequencing (NGS)
- •1.7 Conclusion
- •References
- •2.1 Introduction
- •2.2.1.2 Echinocandins
- •First-Generation Echinocandin
- •Second-Generation Echinocandin
- •2.2.1.3 Other Cell Wall Inhibitors
- •2.2.2.1 Azoles
- •Imidazole
- •Triazole
- •Second-Generation Azole
- •Third-Generation Azole
- •2.2.2.2 Polyenes
- •Other Polyene Under Development
- •2.2.2.3 Allylamines
- •2.2.3 Flucytosine
- •2.3 Conclusion
- •References
- •3.1 Introduction
- •3.2.1 Control Diet
- •3.2.3 Toxification
- •3.2.4 Alternative Treatments
- •3.3.1 Prophylaxis
- •3.3.2 Preemptive Therapies
- •3.3.3 Empirical Therapies
- •3.4 Therapeutic Approach
- •3.4.1 Azoles
- •3.4.2 Echinocandins
- •3.4.3 Polyenes
- •References
- •4.1 Introduction
- •4.3 Eukarya Domain
- •4.4.1 Cryptococcus
- •4.4.2 Aspergillus
- •4.4.3 Mucorales
- •4.4.4 Candida
- •4.5.1 Candida albicans
- •4.5.2 Morphogenesis
- •4.5.3 Pathogenesis
- •4.5.4 Adherence
- •4.5.5 Morphological Switching
- •4.5.6 Invasion
- •4.6 Induced Endocytosis
- •4.7 Active Penetration
- •4.8.2 Biofilm Formation
- •4.8.4.1 Antifungals
- •4.8.4.2 Antifungal Resistance
- •References
- •5.1 Introduction
- •5.2.3.1 Serum
- •5.2.3.2 Low Nitrogen
- •5.2.3.5 Carbon Source
- •5.2.3.6 pH
- •5.2.3.7 N-acetylglucosamine (GlcNAc)
- •5.2.3.8 Quorum Sensing Molecule
- •5.5.5 Surface Colonization Factor1 (SCF1)
- •5.5.6 Other Putative Adhesins
- •5.6.1 Phospholipases
- •5.6.2 Proteinases
- •5.6.3 Hemolysins
- •5.6.4 Lipases
- •5.7 Secreted Cytolytic Peptide: Candidalysin
- •5.5.1 ALS Family
- •5.5.2 HWP Adhesin
- •5.5.3 HYR/IFF Family
- •5.5.4 EPA Family
- •5.9.2 Low Molecular Weight Hsp/Small Heat Shock Proteins
- •5.10.1 Amino Acid/Nitrogen Metabolism
- •5.10.1.1 Amino Acid Sensing Pathway
- •5.12.1.1 Glycolysis
- •5.12.1.2 Gluconeogenesis
- •5.12.1.3 Glyoxylate Cycle
- •5.12.1.4 Fatty Acid Oxidation
- •5.12.3.2 Iron Metabolism
- •5.12.3.3 Candida Iron Transport
- •5.12.3.4 Reductive System
- •5.12.3.5 Siderophore Uptake System
- •5.12.3.6 Haemoglobin-Iron Uptake System
- •5.13.2 Zinc Metabolism
- •References
- •6.1 Introduction
- •6.2 Morphological Switching
- •6.3 Phenotypic Switching
- •6.4 Biofilm Formation
- •6.5 Metabolic Flexibility
- •6.8.1 Hemolysin
- •6.8.2 Phospholipases
- •6.8.3 Proteinase
- •6.8.4 Candidalysin
- •6.12 Conclusion
- •References
- •7.1 Introduction
- •7.2.4 Polymorphism
- •7.2.5.1 Secreted Aspartyl Proteinases
- •7.2.5.2 Phospholipase
- •7.2.6 Calcineurin-Signalling Pathway
- •7.2.7 Ion Homeostasis
- •7.2.7.1 Iron
- •7.2.7.2 Copper
- •7.2.8.1 Capsule
- •7.2.8.2 Melanin
- •7.2.8.3 Heat Shock Proteins
- •7.3 Conclusions
- •References
- •8.1 Introduction
- •8.4.1 ATP-Binding Cassette (ABC) Transporters
- •8.4.2 Major Facilitator Superfamily (MFS) Transporter
- •8.5.1 Biofilm Architecture Among Candida Species
- •References
- •9.1 Introduction
- •References
- •10.1 Introduction
- •10.3 Biofilm
- •10.5 Adherence
- •10.6 Maturation
- •10.8 Dispersion
- •10.11 Animal Models
- •10.18 Photodynamic Therapy
- •References
- •11.1 Introduction
- •11.9 Concluding Remarks
- •References
- •12.1 Introduction
- •12.2 Epidemiology
- •12.3.1 Humoral Response
- •12.3.2 Cellular Immunity
- •12.4 Virulence Factors
- •12.6.1 Fluconazole
- •12.6.2 Polyenes
- •12.6.3 Echinocandins
- •12.7 Drug Resistance
- •12.8 Future Prospects
- •12.9 Conclusions
- •References
- •13.1 Introduction
- •13.4 Translation Research
- •13.4.1 Disease-Oriented Translational Research
- •13.4.2 Lab-Oriented Translational Research
- •13.4.3 Patient-Oriented Translational Research
- •13.5 Conclusion
- •References
- •14.1 Introduction
- •14.2.3 Cutaneous Aspergillosis
- •14.2.4 Ocular Aspergillosis
- •14.2.5 Aspergillus Endocarditis
- •14.2.6 Aspergillus Osteomyelitis
- •14.2.7 Sinus Aspergillosis
- •14.3.2 Histopathology
- •14.3.3 Serological
- •14.3.4 Breath Testing
- •14.3.5 Monoclonal Antibody (mAbs)-Mediated Methods
- •14.4.1 Conventional Therapeutics
- •14.4.1.1 Azoles
- •14.4.1.2 Polyenes
- •14.4.1.3 Echinocandins
- •14.4.1.4 Fluoropyrimidines
- •14.5 Nonconventional Therapeutics
- •14.5.1 Vaccine
- •14.5.2 Monoclonal Antibodies (mAbs)
- •14.5.3 Nanotechnology-Based Therapeutics
- •14.5.4 Immune Therapy
- •14.5.5 Combination Therapy
- •14.8 Conclusion
- •References
- •15: Aspergillus Therapeutics: Future Agents
- •15.1 Introduction
- •15.2.1 Fosmanogepix
- •15.2.2 Ibrexafungerp
- •15.2.3 Olorofim
- •15.2.4 Opelconazole
- •15.2.5 Rezafungin
- •15.2.6 MGCD290
- •15.2.7 Tetrazoles (VT-1129/VT-1161/VT-1598)
- •15.2.8 Nikkomycin Z
- •15.2.9 VL-2397
- •15.2.10 T-2307/ATI-2307
- •15.2.11 Encochleated Amphotericin-B
- •15.2.12 SUBA-Itraconazole
- •15.2.13 Immunotherapy
- •15.2.14 Drug Repurposing
- •References
- •16.1 Introduction
- •16.2 Antifungal Agents
- •16.2.1 Azoles
- •16.2.2 Posaconazole
- •16.2.3 Isavuconazole
- •16.2.4 SUBA—Itraconazole
- •16.2.5 Nanovoriconazole
- •16.2.6 Adverse Effects
- •16.3 Liposomal Amphotericin B (LAMB)
- •16.3.1 Echinocandins
- •16.4 Combination Antifungal Therapy
- •16.5 Therapeutic Drug Monitoring (TDM)
- •16.5.1 Azole-Resistant Aspergillus Spp.
- •16.6 Guideline Recommendations
- •16.10 Conclusion
- •References
- •17.1 Introduction
- •17.3 Potent Antifungal Molecules Under Investigations
- •References
- •19.2 Host–A. fumigatus Interactions
- •19.3.1 Hydrophobicity or Rodlet Layer
- •19.3.2 Conidiation
- •19.3.3 DHN Melanin
- •19.3.5 Siderophores
- •19.3.6 Biofilm Formation
- •19.4 Conclusion
- •References

5 Surviving the Storm: How Candida Species Master Adaptation…
obtain energy in a nutritionally starved macrophage environment. The proline catabolism feeds the TCA cycle, generates electron donors, regulates ATP production, and
activates hyphal morphogenesis through the cAMP/PKA pathway, contributing to the
virulence of C. albicans (Silao and Ljungdahl 2021; Silao etal. 2019).
The methionine metabolism, along with the Mup1 transporter, regulates pathogenic traits like lamentation, biolm formation, escape from macrophage, and systemic mice infection. S-adenosylmethionine (SAM) decarboxylates methionine and
yields spermine and spermidine, activating the cAMP/PKA pathway, hence hyphal
induction. Alternatively, CaDUR3 and CaDUR31 are polyamine transporters that
transport spermine, and spermidine in this process also generates ammonia. Hence,
DUR31 is necessary for alkalization, morphogenesis, and hyphal induction. Also,
CaGap4 uptake SAM induces this pathway directly (Kraidlova etal. 2016; Schrevens
etal. 2018). Hence, the methionine pathway regulates the virulence of C. albicans,
making it a crucial nonpreferred nitrogen source.
The intricate regulatory networks governing nitrogen and amino acid metabolism are pivotal contributors to Candida pathogenesis, orchestrating the survival
and virulence of these opportunistic pathogen.
137
5.12 Role ofCarbon Metabolism inCandida Species
Candida spp. have mastered the art of thriving in diverse host environments by efciently harnessing various carbon sources, including fermentable and nonfermentable compounds like lactate, acetate, etc. This adaptability is crucial for their ability
to cause infections in diverse niches, such as the host vagina or gut and survive
within macrophages, where carbon sources exhibit considerable variability (Ene
etal. 2014; Lok etal. 2021). An in-depth understanding of the mechanisms and
regulators governing carbon metabolism in Candida spp. is instrumental in identifying potential therapeutic targets to combat these infections.
5.12.1 Pathways ofCarbon Metabolism
Carbohydrates are the primary carbon source, and glycolysis is engaged in their
breakdown, whilst alternative carbon source utilization involves gluconeogenesis,
the glyoxylate cycle, and fatty acid oxidation.
5.12.1.1 Glycolysis
Glycolysis is the fundamental process through which the preferred carbon source,
glucose, is converted to pyruvate and is essential for respiration and fermentation.
The Snf3 and Rgt2 are involved in the transport of glucose into cells in S. cerevisiae
(Brown etal. 2006; Johnston and Kim 2005). In C. albicans, Hgt4 is its orthologue,
acting as a glucose sensor that regulates hexose transporter genes. The transcription
factors Tye7 and Gal4, in C. albicans, regulate the glycolytic genes unlike GCR1/2
in S. cerevisiae (Askew etal. 2009; Clifton etal. 1978; Uemura and Fraenkel 1990) .

138
A. Rana et al.
5.12.1.2 Gluconeogenesis
This process involves the synthesis of glucose from nonfermentable carbon sources
such as lactate and glycerol. In C. albicans, gluconeogenesis, which appears to be
similar to S. cerevisiae, may be involved in delivering carbohydrates for cell wall
formation (Eschrich etal. 2002).
5.12.1.3 Glyoxylate Cycle
The glyoxylate cycle is a modied version of the TCA cycle in which fatty acids or
C2 units such as ethanol or acetate can be used as carbon sources. Isocitrate lyase
(ICL1) and malate synthase (MLS1) are important enzymes found in this cycle and
exhibit high homology between S. cerevisiae and C. glabrata (Chew etal. 2019a;
Dunn etal. 2009).
5.12.1.4 Fatty Acid Oxidation
This cycle involves the breakdown of fatty acids into Acetyl-CoA molecules. These
can subsequently be converted into Carbon dioxide and hexose through the preceding processes, reducing the equivalent from the electron transport chain. While
C. albicans lacks the S. cerevisiae oxidation regulators OAF1 and PIP2, it exhibits
similarities with the lamentous fungus Aspergillus nidulans CTF1 transcription
factors, which control oxidation genes, including the obligatory enzyme FOX2
(Piekarska etal. 2006; Ramirez and Lorenz 2009; Rottensteiner etal. 2003).
5.12.2 Carbon Catabolite Repression (CCR)/Glucose
Repression Pathway
The CCR pathway governs the utilization of favored carbon sources, such as glucose, rather than other carbon sources. In S. cerevisiae, glucose effectively prevents
the use of alternative carbon sources. Whereas C. albicans has exibility in carbon
utilization as its catabolite inactivation at the protein level remains stable even without ubiquitination target sites. The key regulators in Candida albicans include the
serine-threonine kinase SNF1 and its activator Sak1 (SNF1 activating kinase). They,
together with downstream effectors Mig1 and Mig2, govern C. albicans’ alternative
carbon utilization, and their absence reduces C. albicans pathogenicity (Ries etal.
2018; Lagree etal. 2020; Ramirez-Zavala etal. 2017).
5.12.3 Role ofCarbon Metabolism Regulators
inCandida Pathogenesis
Candida sp., such as C. albicans and C. glabrata, heavily depend on a spectrum of
carbon sources like glucose and alternative sources like ethanol, acetate, and lactate
for host colonization and exert their pathogenic potential. The glycolytic pathway is
primarily responsible for sugars processing and is crucial for systemic C. albicans
infections. Mutations affecting glycolysis regulators, such as Tye7 and Gal4, have

5 Surviving the Storm: How Candida Species Master Adaptation…
139
been linked to reduced virulence in infection models like Galleria mellonella and
mice (Askew etal. 2009; Barelle etal. 2006).
When internalized by macrophages, both C. albicans and C. glabrata activate
alternative carbon metabolism pathways, including the glyoxylate pathway, gluconeogenesis, and β-oxidation, due to the glucose-depleted macrophage environment.
Moreover, C. albicans cells grown on alternative carbon sources display increased
resistance to cell wall and osmotic stress, and enhanced resilience against antifungals. Notably, C. albicans cultured in lactate-enriched conditions exhibit heightened
virulence in both systemic and vaginal mouse models. Harassing acetate and lactate
in the gastrointestinal and urogenital tracts provides Candida with supplementary
carbon sources that signicantly boost its pathogenicity and tness within the host
(Lorenz etal. 2004; Lok etal. 2021; Chew etal. 2019b; Rai etal. 2012). Mutation
in glyoxylate cycle enzyme ICL1 observed in both C. albicans and glabrata prevents growth on alternative carbon sources like ethanol, acetate, and oleic acid.
ICL1 is a promising therapeutic target as it is activated during macrophage engulfment and the gene mutants exhibit signicant attenuation in the invasive candidiasis
model (Lorenz etal. 2004; Barelle etal. 2006; Chew etal. 2019b; Rai etal. 2012).
Similarly, mutation in genes FOX2 (β-oxidation functional protein) and FBP1
(fructose- 1,6-biphosphatase) also attenuated virulence in mice models (Ramirez
and Lorenz 2007; Lorenz and Fink 2001). The CCR pathway in C. albicans allows
for utilizing various alternative carbon sources, even in the presence of glucose. The
regulators of this pathway signicantly impact the fungus’s ability to cause infections. Deleting the SNF1 showed that the mutant can grow well under specic conditions. Sak1 controls genes related to alternative carbon metabolism, and its
mutants exhibit different survival abilities in mice. Mutations of downstream regulators Mig1 and Mig2in C. albicans result in defective biolm formation, lament
growth, and more sensitivity to the antifungal drug caspofungin, which affected its
virulence (Lagree etal. 2020; Ramirez-Zavala et al. 2017; Mottola etal. 2020).
Hence, the alternative carbon pathways are crucial for Candida’s ability to cause
infections as the fungus can quickly grow on these carbon sources in the body and
establish itself as a solid commensal and opportunistic pathogen.
5.12.3.1 Role ofMicronutrient Metabolism ofCandida spp.
fortheSurvival andHost Infection
Micronutrients, particularly zinc and iron, are vital for various cellular processes,
including DNA replication and gene regulation and their participation in metal
cofactors within proteins (Waldron etal. 2009; Colvin etal. 2010). Fungal pathogens, when thriving in mammalian hosts, require these trace metals for their survival. To combat this, hosts employ nutritional immunity, manipulating metal
availability to limit pathogen growth either by metal starvation or overdose, effectively acting as a defence against infections (Hood and Skaar 2012).
5.12.3.2 Iron Metabolism
Iron, an indispensable trace element, governs numerous biological functions,
including DNA repair, metabolism, and protein synthesis. The bioavailability of

140
iron is less; hence, the mammalian host cleverly hoards iron through nutritional
immunity, denying fungal pathogens access to it. Haemoglobin and transferrin are
iron storage protein that sequesters iron. Intracellularly, lactoferrin and NRAMP1
store iron, thus denying fungal pathogens access to this vital nutrient. Hence, overcoming iron starvation and maintaining balance is an important pathogenic and
virulent trait of almost all fungal pathogens (Cellier etal. 2007; Nairz etal. 2010;
Devaux and Thiebaut 2019).
A. Rana et al.
5.12.3.3 Candida Iron Transport
In the intricate symbiotic relationship between C. albicans and its host, the fungus
employs three sophisticated iron acquisition and transport strategies. Most of the
knowledge comes from studies in S. cerevisiae.
5.12.3.4 Reductive System
This system involves the conversion of ferric iron into soluble ferrous iron through
the enzymatic activity of plasma membrane-localized ferric reductase enzymes
known as C1 (Fre1) and C95 (Fre10, Rbt2) (Xu etal. 2014; Yu etal. 2014). A
multicopper ferroxidase enzyme called Fet3 (S. cerevisiae) catalyzes the reoxidation of ferrous ions to ferric state through a ferroxidation reaction (Philpott and
Protchenko 2008). Ftr1 is the iron permease protein that transports ferrous ions
(Ziegler etal. 2011).
5.12.3.5 Siderophore Uptake System
While S. cerevisiae, C. albicans, and C. glabrata do not synthesize their siderophores, they possess an impressive ability to capture exogenous siderophores produced by other microbes, a credit to their commensal nature. This is achieved
through the expression of plasma membrane transporters belonging to the Sit1/Arn1
family (Fourie etal. 2018; Bairwa etal. 2017).
5.12.3.6 Haemoglobin-Iron Uptake System
The iron-containing proteins, primarily haemoglobin and other molecules like lactoferrin and transferrin, bound a signicant portion of iron in the human body.
C. albicans, however, has evolved a set of proteins bearing the Common in several
Fungal Extracellular Membrane (CFEM) domains, predominantly Rbt5, Pga7,
Pga10, and Csa2, to exploit these iron sources for its nutritional needs (Fourie etal.
2018; Bairwa etal. 2017; Kuznets etal. 2014).
5.13 Regulation ofIron Homeostasis
Candida sp. are commensal pathogens; hence, they experience entirely different iron
concentrations during gut commensalism and host dissemination. Iron underdose and
overdose are both lethal to living Candida spp.; hence, the regulation of iron homeostasis is crucial in Candida (Kronstad 2013). The Sef1-Sfu1 and HAP43 systems in C. albi-
cans are involved in this regulation. During iron deciency in C. albicans, e.g., systemic

5 Surviving the Storm: How Candida Species Master Adaptation…
141
host infection, leads to the activation of a Cys6Zn2 transcription factor termed Sef1,
which activates HAP43, a CCAAT binding transcription factor (Chen etal. 2011; Baek
etal. 2008). HAP43 is required for growth in iron limited condition (Baek etal. 2008;
Singh etal. 2011). HAP43 also represses Sfu1, a GATA-type transcription factor, which
in iron-replete media physically associates and represses Sef1 and hence indirectly
HAP43 (Chen and Noble 2012). In C. glabrata, iron homeostasis is done through Yap5,
a bZIP transcription factor which binds to YRE motifs of the iron-consuming genes.
Still, this binding is not possible without HAP5 binding to the CCAAT motif. Yap5 harbors truncated Hap4L domain, which has conserved CBC(CCAAT Binding Complex)
sites. Hence, Yap5 interacts with CBC for iron stress response (Thiebaut etal. 2017).
5.13.1 Role ofIron Metabolism Regulators inVirulence
Iron metabolism signicantly impacts the virulence and pathogenicity of Candida
spp., including C. albicans, C. glabrata, and C. auris (Bairwa etal. 2017). Iron availability is limited in the host to prevent pathogen access, and excessive iron catalyzes
ROS formation. Candida efciently exploits host iron, impacting its virulence. For
instance, C. glabrata uses host iron stored in phagolysosomes, interfering with the
type-1 interferon system, leading to iron accumulation in macrophages during infection (Riedelberger etal. 2020a). Mutants of C1 in C. albicans display perturbed
responses, like impaired biolm formation, mitochondrial dysfunction, and reduced
virulence in mice (Yu etal. 2014; Hammacott etal. 2000; Xu etal. 2015). Similarly,
in C. auris, disrupting iron homeostasis with pyrvinium pamoate alters carbon and
lipid metabolism and causes mitochondrial dysfunction (Simm etal. 2022). FTR1
and FET3 orthologs in C. albicans and C. glabrata impact organ colonization, and
FET3 mutant in C. parapsilosis showed altered morphology and biolm formation
(Fang and Wang 2002; Ramanan and Wang 2000; Cheng etal. 2013; Lan etal. 2004;
Srivastava etal. 2014; Chakraborty et al. 2020). However, Pga7 involved in heme
acquisition inuences C. albicans virulence (Kuznets etal. 2014). CBC regulators
like HAP43 in C. albicans and HAP5 in C. parapsilosis contribute to virulence with
defective phenotypes in mouse models (Hsu etal. 2011; Toth et al. 2018). Iron
metabolism also regulates yeast-to-hyphae switching in C. albicans, involving
adhesins like ALS3, and similarly in C. glabrata with EPA1 adhesins, establishing a
link between cell morphology and iron uptake (Bairwa etal. 2017; Almeida etal.
2008; Srivastava etal. 2015). Overall, iron metabolism affects various virulence and
pathogenic traits of Candida spp. and additionally has a variety of pleiotropic defects,
highlighting the importance of iron metabolism in Candida pathogenesis.
5.13.2 Zinc Metabolism
Zinc (Zn2+) is the second essential trace metal after iron and is vital both for humans
and fungal pathogens (Andreini etal. 2009). The zinc element has structural, catalytic,
and regulatory functions in humans (Maret and Li 2009). It is present in the catalytic

142
centre of numerous proteins and regulates multiple cellular signalling networks (Alamir
etal. 2021). Whereas in C. albicans, the proteins like SODs (superoxide dismutase)
and transcription factors like Rim101 and Nrg1 are Zn2+ depended and attenuate virulence. Others like Suc1, involved in sugar metabolism, Cwt1in cell wall remodelling,
and Upc2in ergosterol biosynthesis, all require Zn2+. Hence, access to Zn2+ is essential
for host and Candida spp. survival (Alamir etal. 2021; Staats etal. 2013).
A. Rana et al.
5.13.3 Regulation ofZinc Homeostasis andIts Role
inCandida Pathogenesis
Zinc plays a pivotal role in Candida pathogenicity, with the Zap1 transcription factor
initially studied in S. cerevisiae regulating zinc uptake during zinc scarcity by binding to Zn2+ responsive elements in target genes, including its regulation (Eide 2004).
In C. albicans, Sut1 activates Zap1 (Csr1), triggering the expression of zinc trans-
porters (Zrt2 and Zrt3) and the zincosome importer Zrc1 (Alamir etal. 2021; Soares
etal. 2020). Zrt1 is expressed under neutral/alkaline conditions and relies on Pra1
expressed during host cell invasion, and they both transport Zn2+ into the cytoplasm
(Citiulo etal. 2012). In acidic and alkaline environments, Zrt2 functions as a zinc
transporter (Crawford etal. 2018). Zinc, once in the cytoplasm, is transported to the
nucleus, ER, and vacuole by specic transporters like Zrt3 (on vacuoles). In contrast,
Zrc1 (a CDF family transporter in the vacuole) manages zinc detoxication and storage (Crawford et al. 2018; Bird and Wilson 2020; MacDiarmid et al. 2003).
Disruptions in zinc metabolism, as seen in Zap1 mutants of C. albicans, result in
diminished lamentation, altered biolm formation, defective hyphae formation, and
reduced immunityin vivo mice model (Xu etal. 2015; Kim etal. 2008; Nobile etal.
2009; Bottcher etal. 2015). Similarly, Sut1 mutants also exhibit impaired invitro
survival, a decit compensated by ZAP1 overexpression (Xu etal. 2015). In C. dub-
liniensis, the csr1∆/∆ shows reduced virulence in the embryonated chicken egg
model (Bottcher etal. 2015). Zinc dysregulation leads to high levels of reactive oxygen species (ROS) and affects virulence factors like superoxide dismutase (SODs)
and metalloproteases (Staats etal. 2013). Though the deletion of specic zinc transporters like Zrt1,2 and Zrc1 did not affect survival in the Galleria mellonella model
in C. parapsilosis, it suggested the potential use of zinc-based poisoning by macro-
phages to eliminate the pathogen (Bottcher etal. 2015). In the phagosomally trapped
C. glabrata, zinc is transported via zinc transporters with metallothionein acting as
zinc chaperons causing zinc toxicity (Riedelberger etal. 2020b).
5.14 Conclusions andFuture Perspective
Candida infections are a growing concern in the healthcare sector, primarily due
to the emergence of drug-resistant strains, particularly non-albicans Candida spp.
While Candida, including the common C. albicans, is often harmless in healthy
individuals, it can seriously threaten those with compromised immune systems.

5 Surviving the Storm: How Candida Species Master Adaptation…
143
The escalation of resistance to antifungal drugs like azoles and echinocandins is a
signicant issue, as these drugs are the primary treatment options for invasive
candidiasis. In particular, strains such as C. glabrata and C. auris have gained
notoriety for their extreme drug resistance, rendering traditional antifungals less
effective. This scenario is becoming more complex due to the increasing population of individuals with compromised immune systems, poor drug efcacy, and
associated host toxicity. These things will overburden healthcare facilities; moreover, there is a looming vulnerability of Candida infection outbreaks. One promising strategy is to target various factors that make Candida virulent, such as
biolm formation, phospholipase activity, and adhesin production. These virulent
factors are crucial in the pathogen’s ability to inltrate, persist within, and disseminate throughout the host. By gaining a deeper understanding of these virulence traits’ molecular and metabolic regulation, it may be possible to develop
interventions that can prevent their production. This could disrupt the interaction
between the host and Candida, potentially leading to the creation of more effective therapeutics. This approach should extend beyond C. albicans to encompass
lesser known but equally or more potent non-albicans Candida sp. like C. gla-
brata, C. auris, and C. parapsilosis. These efforts could broaden the library of
effective compounds against Candida infections and reduce selective pressure on
currently limited antifungal drugs (Arendrup and Patterson 2017; Taei etal. 2019;
Ahmad Khan etal. 2020).
This chapter explores a great diversity of virulence factors utilized by Candida
species for host interaction. Candida species has a diverse array of virulent factors
that regulate its morphology, adhesion, and arsenal of enzymes, including candidalysin, which aids host barrier degradation. Candida spp. also possess a multitude of regulators that enable them to sense and adapt to changes in pH and
temperature, maintaining the optimal conditions for various proteins crucial to
their survival. Successfully colonizing nutritionally starved host niches, like the
vaginal and gastrointestinal linings and host phagosomes, demands remarkable
metabolic adaptation. Candida spp. metabolic exibility and the factor it employs
to secure various macro nutrients and micronutrients are explored within this
review. Additionally, the intricate network of signalling pathways and gene regulators that govern these virulent factors are discussed. Notably, the absence of
specic elements in different infectious traits renders Candida spp. avirulent invitro or invivo settings, underscoring their pivotal role in Candida pathogenicity.
The future of fungal therapeutics hinges on our ability to characterize and
target these factors, both already known and undiscovered or underexplored but
possessing distinct roles in Candida’s pathogenesis. Achieving this milestone in
fungal therapeutics necessitates a comprehensive understanding of these factors
and taking them to clinical trials. Furthermore, in our pursuit of combating
drug-resistant candidiasis, we must pay equal attention to NCAS as they rapidly
develop resistance. Continual progress in unravelling the signicance of these
virulent traits holds the key to overcoming the challenges posed by drugresistant candidiasis.

144
A. Rana et al.
References
Ahmad Khan MS, Alshehrei F, Al-Ghamdi SB, Bamaga MA, Al-Thubiani AS, Alam MZ (2020)
Virulence and biolms as promising targets in developing antipathogenic drugs against candi-
diasis. Future Sci OA 6(2):440
Alamir OF, Oladele RO, Ibe C (2021) Nutritional immunity: targeting fungal zinc homeostasis.
Heliyon 7(8):e07805
Almeida RS, Brunke S, Albrecht A, Thewes S, Laue M, Edwards JE etal (2008) The hyphal-
associated adhesin and invasin Als3 of Candida albicans mediates iron acquisition from host
ferritin. PLoS Pathog 4(11):e1000217
Amorim-Vaz S, Coste AT, Tran VDT, Pagni M, Sanglard D (2021) Function analysis of MBF1,
a factor involved in the response to amino acid starvation and virulence in Candida albicans.
Front Fungal Biol 2:658899
Andreini C, Bertini I, Rosato A (2009) Metalloproteomes: a bioinformatic approach. Acc Chem
Res 42(10):1471–1479
Aparna T, Raphy HM, Harish Kumar KS, Innu S (2023) Phospholipase, proteinase, esterase and
haemolytic activity of Candida species isolated from oral cavity and its antifungal susceptibil-
ity pattern. Int J Res Med Sci 11:2476
Araújo D, Henriques M, Silva S (2017) Portrait of Candida species biolm regulatory network
genes. Trends Microbiol 25(1):62–75
Arendrup MC, Patterson TF (2017) Multidrug-resistant Candida: epidemiology, molecular mecha-
nisms, and treatment. J Infect Dis 216(Suppl 3):S445–S451
Askew C, Sellam A, Epp E, Hogues H, Mullick A, Nantel A et al (2009) Transcriptional regu-
lation of carbohydrate metabolism in the human pathogen Candida albicans. PLoS Pathog
5(10):e1000612
Baek YU, Li M, Davis DA (2008) Candida albicans ferric reductases are differentially regulated
in response to distinct forms of iron limitation by the Rim101 and CBF transcription factors.
Eukaryot Cell 7(7):1168–1179
Bairwa G, Hee Jung W, Kronstad JW (2017) Iron acquisition in fungal pathogens of humans.
Metallomics 9(3):215–227
Barelle CJ, Priest CL, Maccallum DM, Gow NA, Odds FC, Brown AJ (2006) Niche-specic regu-
lation of central metabolic pathways in a fungal pathogen. Cell Microbiol 8(6):961–971
Bastidas RJ, Heitman J, Cardenas ME (2009) The protein kinase Tor1 regulates adhesin gene
expression in Candida albicans. PLoS Pathog 5(2):e1000294
Becker JM, Kauffman SJ, Hauser M, Huang L, Lin M, Sillaots S etal (2010) Pathway analysis of
Candida albicans survival and virulence determinants in a murine infection model. Proc Natl
Acad Sci 107:22044–22049
Bensen ES, Martin SJ, Li M, Berman J, Davis DA (2004) Transcriptional proling in Candida
albicans reveals new adaptive responses to extracellular pH and functions for Rim101p. Mol
Microbiol 54(5):1335–1351
Bentz ML, Sexton DJ, Welsh RM, Litvintseva AP (2019) Phenotypic switching in newly emerged
multidrug-resistant pathogen Candida auris. Med Mycol 57(5):636–638
Bing J, Guan Z, Zheng T, Zhang Z, Fan S, Ennis CL etal (2023) Clinical isolates of Candida auris
with enhanced adherence and biolm formation due to genomic amplication of ALS4. PLoS
Pathog 19(3):e1011239
Bird AJ, Wilson S (2020) Zinc homeostasis in the secretory pathway in yeast. Curr Opin Chem
Biol 55:145–150
Birse CE, Irwin MY, Fonzi WA, Sypherd PS (1993) Cloning and characterization of ECE1, a gene
expressed in association with cell elongation of the dimorphic pathogen Candida albicans.
Infect Immun 61:3648–3655
Biswas K, Morschhäuser J (2005) The Mep2p ammonium permease controls nitrogen starvation-
induced lamentous growth in Candida albicans. Mol Microbiol 56(3):649–669
Biswas B, Rana A, Gupta N, Gupta I, Puria R, Thakur A (2023a) A novel robust method mimicking
human substratum to dissect the heterogeneity of Candida auris biolm formation. Microbiol
Spectr 11(4):e0089223

5 Surviving the Storm: How Candida Species Master Adaptation…
Biswas B, Gangwar G, Nain V, Gupta I, Thakur A, Puria R (2023b) Rapamycin and Torin2 inhibit
Candida auris TOR: insights through growth proling, docking, and MD simulations. J Biomol
Struct Dyn 41(17):8445–8461
Borman AM, Szekely A, Johnson EM (2016) Comparative pathogenicity of united kingdom
isolates of the emerging pathogen Candida auris and other key pathogenic Candida species.
mSphere 1(4):e00189-16
Bottcher B, Palige K, Jacobsen ID, Hube B, Brunke S (2015) Csr1/Zap1 maintains zinc homeo-
stasis and inuences virulence in Candida dubliniensis but is not coupled to morphogenesis.
Eukaryot Cell 14(7):661–670
Brega E, Zufferey R, Mamoun CB (2004) Candida albicans Csy1p is a nutrient sensor important
for activation of amino acid uptake and hyphal morphogenesis. Eukaryot Cell 3(1):135–143
Brown V, Sexton JA, Johnston M (2006) A glucose sensor in Candida albicans. Eukaryot Cell
5(10):1726–1737
Brown JL, Delaney C, Short B, Butcher MC, McKloud E, Williams C etal (2020) Candida auris
phenotypic heterogeneity determines pathogenicity invitro. mSphere 5(3):e00371-20
Burnie JP, Carter TL, Hodgetts SJ, Matthews RC (2006) Fungal heat-shock proteins in human
disease. FEMS Microbiol Rev 30:53–88
Calcagno AM, Bignell E, Warn P, Jones MD, Denning DW, Mühlschlegel FA etal (2003) Candida
glabrata STE12 is required for wild-type levels of virulence and nitrogen starvation induced
lamentation. Mol Microbiol 50(4):1309–1318
Cao F, Lane S, Raniga PP, Lu Y, Zhou Z, Ramon K etal (2006) The Flo8 transcription factor is essen-
tial for hyphal development and virulence in Candida albicans. Mol Biol Cell 17(1):295–307
Cashikar AG, Duennwald M, Lindquist SL (2005) A chaperone pathway in protein disaggregation:
Hsp26 alters the nature of protein aggregates to facilitate reactivation by Hsp104. J Biol Chem
280:23869–23875
Castaño I, Pan SJ, Zupancic M, Hennequin C, Dujon B, Cormack BP (2005) Telomere length con-
trol and transcriptional regulation of subtelomeric adhesins in Candida glabrata. Mol Microbiol
55(4):1246–1258
Cellier MF, Courville P, Campion C (2007) Nramp1 phagocyte intracellular metal withdrawal
defense. Microbes Infect 9(14–15):1662–1670
Chakraborty T, Toth Z, Toth R, Vagvolgyi C, Gacser A (2020) Iron metabolism, pseudohypha pro-
duction, and biolm formation through a multicopper oxidase in the human-pathogenic fungus
Candida parapsilosis. mSphere 5(3):e00227-20
Chakraborty S, Rahate K, Kumar C, Idicula-Thomas S (2023) Expanding the therapeutic options
for Candida infections using novel inhibitors of secreted aspartyl proteases. Drug Dev Res
84:96–109
Chen C, Noble SM (2012) Post-transcriptional regulation of the Sef1 transcription factor controls
the virulence of Candida albicans in its mammalian host. PLoS Pathog 8(11):e1002956
Chen C, Pande K, French SD, Tuch BB, Noble SM (2011) An iron homeostasis regulatory circuit
with reciprocal roles in Candida albicans commensalism and pathogenesis. Cell Host Microbe
10(2):118–135
Cheng X, Xu N, Yu Q, Ding X, Qian K, Zhao Q et al (2013) Novel insight into the expression
and function of the multicopper oxidases in Candida albicans. Microbiology (Reading) 159(Pt
6):1044–1055
Chew SY, Ho KL, Cheah YK, Ng TS, Sandai D, Brown AJP etal (2019a) Glyoxylate cycle gene
ICL1 is essential for the metabolic exibility and virulence of Candida glabrata. Sci Rep
9(1):2843
Chew SY, Chee WJY, Than LTL (2019b) The glyoxylate cycle and alternative carbon metabolism
as metabolic adaptation strategies of Candida glabrata: perspectives from Candida albicans and
Saccharomyces cerevisiae. J Biomed Sci 26(1):52
Citiulo F, Jacobsen ID, Miramon P, Schild L, Brunke S, Zipfel P et al (2012) Candida albicans
scavenges host zinc via Pra1 during endothelial invasion. PLoS Pathog 8(6):e1002777
Clifton D, Weinstock SB, Fraenkel DG (1978) Glycolysis mutants in Saccharomyces cerevisiae.
Genetics 88(1):1–11
145

146
Cloutier M, Ro C, Bolduc N, Zelada A, Martineau P, Bouillon M etal (2003) The two isoforms of
the cAMP-dependent protein kinase catalytic subunit are involved in the control of dimorphism
in the human fungal pathogen Candida albicans. Fungal Genet Biol 38(1):133–141
Colvin RA, Holmes WR, Fontaine CP, Maret W (2010) Cytosolic zinc buffering and mufing:
their role in intracellular zinc homeostasis. Metallomics 2(5):306–317
Cornet M, Gaillardin C, Richard ML (2006) Deletions of the endocytic components VPS28 and
VPS32in Candida albicans lead to echinocandin and azole hypersensitivity. Antimicrob Agents
Chemother 50:3492–3495
Craig EA, Gambill BD, Nelson RJ (1993) Heat shock proteins: molecular chaperones of protein
biogenesis. Microbiol Rev 57:402–414
Crawford AC, Lehtovirta-Morley LE, Alamir O, Niemiec MJ, Alaw B, Alsarraf M etal (2018)
Biphasic zinc compartmentalisation in a human fungal pathogen. PLoS Pathog 14(5):e1007013
Cuéllar-Cruz M, López-Romero E, Ruiz-Baca E, Zazueta-Sandoval R (2014) Differential response
of Candida albicans and Candida glabrata to oxidative and nitrosative stresses. Curr Microbiol
69:733–739
Dabas N, Morschhauser J (2007) Control of ammonium permease expression and lamentous
growth by the GATA transcription factors GLN3 and GAT1in Candida albicans. Eukaryot Cell
6(5):875–888
Dabas N, Morschhauser J (2008) A transcription factor regulatory cascade controls secreted aspar-
tic protease expression in Candida albicans. Mol Microbiol 69(3):586–602
Dai B, Wang Y, Li D, Xu Y, Liang R, Zhao L etal (2012) Hsp90 is involved in apoptosis of Candida
albicans by regulating the calcineurin-caspase apoptotic pathway. PLoS One 7(9):e45109
Danhof HA, Lorenz MC (2015) The Candida albicans ATO gene family promotes neutralization of
the macrophage phagolysosome. Infect Immun 83(11):4416–4426
Davis D, Wilson RB, Mitchell AP (2000) RIM101-dependent and -independent pathways govern
pH responses in Candida albicans. Mol Cell Biol 20(3):971–978
De Bernardis F, Mondello F, Scaravelli G, Pachì A, Girolamo A, Agatensi L et al (1999) High
aspartyl proteinase production and vaginitis in human immunodeciency virus-infected
women. J Clin Microbiol 37:1376–1380
de Groot PW, Bader O, de Boer AD, Weig M, Chauhan N (2013) Adhesins in human fungal patho-
gens: glue with plenty of stick. Eukaryot Cell 12(4):470–481
Deng Y, Li S, Bing J, Liao W, Tao L (2021) Phenotypic switching and lamentation in Candida
haemulonii, an emerging opportunistic pathogen of humans. Microbiol Spectr 9(3):e0077921
Desai C, Mavrianos J, Chauhan N (2011) Candida glabrata Pwp7p and Aed1p are required for
adherence to human endothelial cells. FEMS Yeast Res 11(7):595–601
Devaux F, Thiebaut A (2019) The regulation of iron homeostasis in the fungal human pathogen
Candida glabrata. Microbiology (Reading) 165(10):1041–1060
Dhanasekaran S, Selvadoss PP, Manoharan SS (2023) Anti-fungal potential of structurally diverse
FDA-approved therapeutics targeting secreted aspartyl proteinase (SAP) of Candida albicans:
an in silico drug repurposing approach. Appl Biochem Biotechnol 195:1983–1998
Dunn MF, Ramirez-Trujillo JA, Hernandez-Lucas I (2009) Major roles of isocitrate lyase and
malate synthase in bacterial and fungal pathogenesis. Microbiology (Reading) 155:3166–3175
Eide DJ (2004) The SLC39 family of metal ion transporters. Pugers Arch 447(5):796–800
Ene IV, Brunke S, Brown AJ, Hube B (2014) Metabolism in fungal pathogenesis. Cold Spring
Harb Perspect Med 4(12):a019695
Eschrich D, Kotter P, Entian KD (2002) Gluconeogenesis in Candida albicans. FEMS Yeast Res
2(3):315–325
Eyles SJ, Gierasch LM (2010) Nature’s molecular sponges: small heat shock proteins grow into
their chaperone roles. Proc Natl Acad Sci 107:2727–2728
Fan S, Yue H, Zheng Q, Bing J, Tian S, Chen J etal (2021) Filamentous growth is a general feature
of Candida auris clinical isolates. Med Mycol 59(7):734–740
Fang HM, Wang Y (2002) Characterization of iron-binding motifs in Candida albicans high-
afnity iron permease CaFtr1p by site-directed mutagenesis. Biochem J 368:641–647
A. Rana et al.
Соседние файлы в папке Библиотека им академика М.И. Перельмана
